Advances in CRISPR Gene Editing Offer Hope for Neurodevelopmental Disorders
The article discusses the use of CRISPR activation techniques to address SCN2A-related neurodevelopmental disorders, with data available from RNA sequencing studies and various mouse models, aiming to develop targeted gene therapies.